Abstract |
This double-blind study determined whether daily bathing with an antibacterial soap would reduce the number of Staphylococcus aureus on the skin and result in clinical improvement of atopic dermatitis. For 9 weeks, 50 patients with moderately severe atopic dermatitis bathed daily with either an antimicrobial soap containing 1.5% triclocarban or the placebo soap. They also used a nonmedicated moisturizer and 0.025% triamcinolone acetonide cream as needed, but the availability of the corticosteroid cream was discontinued after 6 weeks. The antimicrobial soap regimen caused significantly greater improvement in the severity and extent of skin lesions than the placebo soap regimen, which correlated with reductions both in S aureus in patients with positive cultures at baseline and in total aerobic organisms. Outcome measures included reductions in S aureus, total aerobic organisms, and dermatologic assessments. Overall, daily bathing with an antibacterial soap was well tolerated, provided clinical improvement, and reduced levels of skin microorganisms.
|
Authors | D L Breneman, J M Hanifin, C A Berge, B H Keswick, P B Neumann |
Journal | Cutis
(Cutis)
Vol. 66
Issue 4
Pg. 296-300
(Oct 2000)
ISSN: 0011-4162 [Print] United States |
PMID | 11109156
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents, Local
- Carbanilides
- triclocarban
|
Topics |
- Adolescent
- Adult
- Aged
- Analysis of Variance
- Anti-Infective Agents, Local
(administration & dosage)
- Baths
- Carbanilides
(administration & dosage)
- Child
- Dermatitis, Atopic
(microbiology)
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Staphylococcal Skin Infections
(drug therapy)
- Staphylococcus aureus
(drug effects, isolation & purification)
|